Home  >  Products  >  ALLC (allantoicase ) Blocking Peptide (the N terminal of ALLC)(100ug)
ALLC (allantoicase ) Blocking Peptide (the N terminal of ALLC)(100ug)

ALLC (allantoicase ) Blocking Peptide (the N terminal of ALLC)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ALLC Antibody (ARP57250_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57250
Size: 100ug
Weight: 43kDa
Gene: 55821
Format: Lyophilized powder
Target: Allantoicase (EC 3.5.3.4) participates in the uric acid degradation pathway. Its enzymatic activity, like that of urate oxidase (MIM 191540), was lost during vertebrate evolution.
Alternative names: ALC